Pricing

CoLucid Pharmaceuticals Inc (CLCD)

followers ·
Sector: HEALTH CARE
Industry: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS
CEO: Thomas P. Mathers
Employees: 7
Web site: http://www.colucid.com
222 THIRD STREET, CAMBRIDGE, MA, 02142
781-365-2596

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

All 13F Filers Prior Change Hedge Funds 1 Prior Change
CoLucid Pharmaceuticals, Inc., a biopharmaceutical company, develops small molecules for the acute treatment of migraine. Its lead product candidate is Lasmiditan, an oral tablet that is in Phase III clinical program for the acute treatment of mig...
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available